About this trial
The goal of this study is to determine whether the Achieving Health in Emerging Adults with Diabetes (AHEAD) Program helps emerging adults with type 1 diabetes improve their blood glucose management during the transition from pediatric to adult care.
Participants will be randomized to receive Usual Care or the AHEAD Program, which provides tailored support to emerging adults to build autonomy and competence to facilitate independent diabetes management. Researchers will compare changes in glycemia and participant-reported outcomes between groups.
Eligibility criteria
Qualifiers
16-19 years of age
Have had type 1 diabetes ≥ 12 months
Had a recent HbA1c ≥7.0%
Currently receive outpatient diabetes care at a Seattle Children's Hospital Diabetes Clinic located in Bellevue, Everett, Federal Way, or Seattle
Disqualifiers
Have had a pilot program AHEAD clinic visit
Most recent Usual Care diabetes visit was with a current AHEAD provider
Trial design
Treatments tested in this trial
- AHEAD Program
Treatment groups
Sponsors and collaborators
University of British Columbia
Lead sponsor
Breakthrough T1D
Collaborator
Seattle Children's Hospital
Collaborator
University of Washington
Collaborator
Kaiser Permanente
Collaborator